For full functionality of this page it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser Pharmaceutical Industry Category Archives
US Flag
UK Flag

Category: Pharmaceutical Industry

Dec
17

Here’s Why Recall and Liability Claim Trends Are On The Rise

As we head into a new year, we’ve spotted a new trend impacting companies across all industries: product recalls are becoming more frequent, complex, and expensive. Based on our experience and analysis of the data, advanced technology, more efficient processes, complex supply chains and increasingly sophisticated products are creating more risks and challenges. Combine that with regulators’ increased focus on enforcing product safety policies globally, and it’s highly likely this global trend will continue.

Continue Reading
Dec
01

Here’s What You Need To Know About Fraudulent Claims and Phony COVID-19 Products

From teas and essential oils to drugs, faulty masks, and other medical products, COVID-19 has brought a wave of deceptive marketing and fraud.Early on in the pandemic, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent

Continue Reading
Nov
25

The Recall Trends and Data You Need in The Final Months of The Year

The latest data from our Third Edition Recall Index, the leading recall insights report, confirms recall activity has remained steady, for the most part, for the last 10 months despite the COVID-19 pandemic. However, with cases surging and a turbulent holiday season fast approaching, product safety challenges are on track to be even more difficult to manage as 2020 ends.

Continue Reading
Sep
23

What The FDA’s Nitrosamine Impurity Guidance Means for Drug Manufacturers

It’s been over two years since carcinogenic nitrosamines were discovered in some widely used drugs. The discovery occurred in 2018 when the contaminant was found in active pharmaceutical ingredients in Valsartan, a blood pressure medication. Since then, the contaminant has been found in several other drugs taken by millions of people each year. The Latest Update In 2019, the contaminant was found in ranitidine medications (commonly known as Zantac) and Nizatidine.

Continue Reading
Jul
17

The FDA Resumes Its Random Inspections. Are You Prepared?

The FDA recently announced that its inspectors may be knocking on your door as early as July 20 to conduct long-overdue domestic inspections. Once given the green light, inspectors’ first priority will be to conduct “mission critical” inspections of facilities considered to be of highest risk.

Continue Reading